Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis

T. W. V. Daniels, G. B. Rogers*, F. A. Stressmann, C. J. van der Gast, K. D. Bruce, G. R. Jones, G. J. Connett, J. P. Legg, M. P. Carroll

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Abstract

Background: A diverse array of bacterial species is present in the CF airways, in addition to those recognised as clinically important. Here, we investigated the relative impact of antibiotics, used predominantly to target Pseudomonas aeruginosa during acute exacerbations, on other non-pseudomonal species.

Methods: The relative abundance of viable P. aeruginosa and non-pseudomonal species was determined in sputa from 12 adult CF subjects 21, 14, and 7 days prior to antibiotics, day 3 of treatment, the final day of treatment, and 10-14 days afterwards, by T-RFLP profiling.

Results: Overall, relative P. aeruginosa abundance increased during antibiotic therapy compared to other bacterial species; mean abundance pre-antibiotic 51.0 +/- 36.0% increasing to 71.3 +/- 30.4% during antibiotic (ANOVA: F-1,F-54=5.16; P

Conclusions: Antibiotic treatment directed at P. aeruginosa has an additional significant impact on non-pseudomonal, co-colonising species. (C) 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)22-28
Number of pages7
JournalJournal Of Cystic Fibrosis
Volume12
Issue number1
DOIs
Publication statusPublished - Jan 2013

Keywords

  • Antibiotics
  • Pulmonary exacerbation
  • Bacterial diversity
  • T-RFLP
  • Relative abundance
  • PSEUDOMONAS-AERUGINOSA BIOFILMS
  • LUNG INFECTIONS
  • THERAPY
  • AMINOGLYCOSIDE
  • EXPRESSION
  • PATHOGENS
  • DYNAMICS
  • CELLS

Fingerprint

Dive into the research topics of 'Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis'. Together they form a unique fingerprint.

Cite this